Teva Pharmaceutical Finance Netherlands III BV (TEVA)

No results found for "".

Teva Pharmaceutical Finance Netherlands III BV (TEVA)

C/P	Industry	Status	Ticker(s)	Issuer(s)	Size(m)		Tranches	Region	Date
HYC	HLTH	PRCD	TEVA	Teva Pharmaceutical Finance Netherlands III BV	-		4	EMEA	Mar 6, 2018

Tranche #1Teva Pharmaceutical Finance Netherlands III BV

currency

EUR

size (m)

700.000

maturity

Apr 15, 2022

type

Fixed

tenor

4.000

call

registration

144A/Reg S

benchmark

OBL

ranking

Senior

moody's

Ba2

s&p

fitch

size description

re-open/tap

ipt

ipt-pxd

guidance

3.25-3.50%

spread

342

coupon

3.25%

spread set

price

100.00000

yield

3.25%

book size (m)

peak book (m)

x-covered

book attrition

nic

billing & delivering

active leads

joint leads

,,,,

passive leads

co-managers

coordinating managers

book size (m)

peak book (m)

x-covered

book attrition

nic

billing & delivering

active leads

joint leads

,,,,

passive leads

co-managers

coordinating managers

Tranche #2Teva Pharmaceutical Finance Netherlands III BV

currency

USD

size (m)

1,250.000

maturity

Apr 15, 2024

type

Fixed

tenor

6.000

call

registration

144A/Reg S

benchmark

Tsy

ranking

Senior

moody's

Ba2

s&p

fitch

size description

re-open/tap

ipt

ipt-pxd

guidance

6.00-6.25%

spread

328

coupon

6.00%

spread set

price

100.00000

yield

6.00%

book size (m)

peak book (m)

x-covered

book attrition

nic

billing & delivering

active leads

joint leads

,,,,

passive leads

co-managers

coordinating managers

book size (m)

peak book (m)

x-covered

book attrition

nic

billing & delivering

active leads

joint leads

,,,,

passive leads

co-managers

coordinating managers

Tranche #3Teva Pharmaceutical Finance Netherlands III BV

currency

EUR

size (m)

900.000

maturity

Mar 1, 2025

type

Fixed

tenor

7.000

call

registration

144A/Reg S

benchmark

DBR

ranking

Senior

moody's

Ba2

s&p

fitch

size description

re-open/tap

ipt

ipt-pxd

guidance

4.50-4.75%

spread

420

coupon

4.50%

spread set

price

100.00000

yield

4.50%

book size (m)

peak book (m)

x-covered

book attrition

nic

billing & delivering

active leads

joint leads

,,,,

passive leads

co-managers

coordinating managers

book size (m)

peak book (m)

x-covered

book attrition

nic

billing & delivering

active leads

joint leads

,,,,

passive leads

co-managers

coordinating managers

Tranche #4Teva Pharmaceutical Finance Netherlands III BV

currency

USD

size (m)

1,250.000

maturity

Mar 1, 2028

type

Fixed

tenor

10.000

call

registration

144A/Reg S

benchmark

Tsy

ranking

Senior

moody's

Ba2

s&p

fitch

size description

re-open/tap

ipt

ipt-pxd

guidance

7.00-7.25%

spread

388

coupon

6.75%

spread set

price

100.00000

yield

6.75%

book size (m)

peak book (m)

x-covered

book attrition

nic

billing & delivering

active leads

joint leads

,,,,

passive leads

co-managers

coordinating managers

book size (m)

peak book (m)

x-covered

book attrition

nic

billing & delivering

active leads

joint leads

,,,,

passive leads

co-managers

coordinating managers

Tranche Comments

4 yr: First Pay: 2018-10-15; Registration: 144A/Reg S; Comments: EUR700m 4yr Fxd. snr 144A/Reg S with registration rights. Barc/BAML/BNPP/Citi/CS/MS/RBC/Miz/MUFG/SMBC Nikko. Mixed. Price Talk: 3.25-3.50%. MWC OBL+50bp. (Source: IFR); 6 yr: First Pay: 2018-10-15; Registration: 144A/Reg S; Comments: USD1.25bn 6yr Fxd. snr 144A/Reg S with registration rights. Barc/BAML/BNPP/Citi/CS/MS/RBC/Miz/MUFG/SMBC Nikko. Mixed. Price Talk: 6.00-6.25%. MWC+50bp. (Source: IFR); 7 yr: First Pay: 2018-09-01; Registration: 144A/Reg S; Comments: EUR900m 7yr Fxd. snr 144A/Reg S with registration rights. Barc/BAML/BNPP/Citi/CS/MS/RBC/Miz/MUFG/SMBC Nikko. Mixed. Price Talk: 4.50-4.75%. (Source: IFR); 10 yr: First Pay: 2018-09-01; Registration: 144A/Reg S; Comments: USD1.25bn 10yr Fxd. snr 144A/Reg S with registration rights. Barc/BAML/BNPP/Citi/CS/MS/RBC/Miz/MUFG/SMBC Nikko. Mixed. Price Talk: 7.00-7.25%. MWC+50bp. (Source: IFR);

Guarantor(s)

Teva Pharmaceutical Industries Ltd

Use of Proceeds

General Corporate Purposes

Hide Details

Explore all other Commentary & Deal Flow

Asset Backed Securities

sector/subsector profiles

High Yield

industry/subindustry profiles

Investment Grade

industry/subindustry profiles

Teva Pharmaceutical Finance Netherlands III BV (TEVA)

Deal Details

Commentary

Deal Flow